Robert W. Baird assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research note released on ...
HC Wainwright raised their FY2028 earnings per share (EPS) estimates for Denali Therapeutics in a report issued on Tuesday, January 7th. HC Wainwright analyst A. Fein now expects that the company will ...
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report) yesterday. The company’s ...
GlobalData on MSN16h
IMG Biosciences enacts massive lay-offs after Phase I trial failureFollowing the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.
After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...
20h
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback